Literature DB >> 6251779

Breast cancer in Japan and United States: epidemiology, hormone receptors, pathology, and survival.

R H Yonemoto.   

Abstract

Breast cancer is the most common cancer among American women, whereas in Japan it ranks third behind gastric and uterine cancers. In spite of the relatively low incidence of breast cancer in Japan, a sharp increase in the frequency has been noted since 1966, which is decidedly related to change in dietary patterns in Japanese women. An increase of over 250% in dietary intake of fat has been noted during the past 15 years. Cancer is detected at an earlier stage in Japan as compared with the United States, and consequently the end result is significantly better. But the improved results could not be totally explained on the basis of early detection, since stage-for-stage the Japanese series appears to be consistently better than the US series by 10% in their ten-year survival rates.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251779     DOI: 10.1001/archsurg.1980.01380090036009

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

Review 1.  Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. The Women's Intervention Nutrition Study (WINS).

Authors:  R T Chlebowski; D Rose; I M Buzzard; G L Blackburn; W Insull; M Grosvenor; R Elashoff; E L Wynder
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

2.  Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer.

Authors:  Takao Kato; Francesco Pezzella; Graham Steers; Leticia Campo; Russell D Leek; Helen Turley; Shingo Kameoka; Toshio Nishikawa; Adrian L Harris; Kevin C Gatter; Stephen Fox
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Hormone receptors and obesity in Japanese women with breast cancer.

Authors:  K Kuno; A Fukami; M Hori; F Kasumi
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

4.  Cost of illness of breast cancer in Japan: trends and future projections.

Authors:  Kunichika Matsumoto; Kayoko Haga; Takefumi Kitazawa; Kanako Seto; Shigeru Fujita; Tomonori Hasegawa
Journal:  BMC Res Notes       Date:  2015-10-05

Review 5.  Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.

Authors:  Mark J Messina; Charles E Wood
Journal:  Nutr J       Date:  2008-06-03       Impact factor: 3.271

6.  Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer.

Authors:  T Kato; G Steers; L Campo; H Roberts; R D Leek; H Turley; T Kimura; S Kameoka; T Nishikawa; M Kobayashi; A L Harris; K C Gatter; F Pezzella
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.